The SPAC and its pharma-cannabis target in a filing included an investor presentation covering the revised deal terms. Read more.
Shultze & Clever Leaves File Revised Merger Plan
Related Posts
VIDA FLaSH Trims Deal Size 14% Ahead of $150M IPO
The new SPAC plans to target the healthcare sector in the United States.
7GC Files for $175M IPO
The SPAC is focused on the technology sector.
Roman DBDR Updates Prospectus
The updated filing for the tech-focused SPAC follows a previous filing to downsize its IPO to $220 million from $275 million.
Novus Files 5th Prospectus Amendment on AppHarvest Deal
A date for the shareholder vote on the $532.2 million deal has not been set, according to the filing.